A. Ha and E. L. , Lysergic acid diethylamide (LSD 25). II. Psychobiological effects on the Siamese fighting fish, Science, vol.12, issue.1203128, pp.990-991, 1954.

V. Arvanov and W. R. , 03) M100907, a selective 5-HT2A receptor antagonist and a potential antipsychotic drug, facilitates N-methyl-D-aspartate-receptor mediated neurotransmission in the rat medial prefrontal cortical neurons in vitro, 1998.

J. C. Baggott, Abnormal visual experiences in individuals with histories of hallucinogen use : A web-based questionnaire? . Drug and Alcohol Dependence, pp.61-67, 2011.

S. Barker and M. E. , A critical review of reports of endogenous psychedelic N, Ndimethyltryptamines in humans: 1955-2010, Drug Test Anal, pp.7-08, 2012.

A. Bernardi, L'ayahuasca, le serpent et moi [Film]. France: Artline Films, 2003.

R. Berman and C. A. , Antidepressant effects of ketamine in depressed patients, Biological Psychiatry, vol.47, issue.4, 2000.
DOI : 10.1016/S0006-3223(99)00230-9

M. Bliss, 03) Datura Plant Poisoning, Clinical Toxicology review, vol.23, p.6, 2001.

F. Bois-mariage, Ayahuasca : une synth??se interdisciplinaire, Psychotropes, vol.8, issue.1, 2002.
DOI : 10.3917/psyt.081.0079

K. Bonson and B. J. , 06) Chronic administration of serotonergic antidepressants attenuates the subjective effects of LSD in humans, Neuropsychopharmacology, issue.6, pp.14425-14461, 1996.

C. C. Bourgey-anne, Drogues & Voyages, 2005.

. Brennan, AMPA/Kainate Receptor Antagonists as Novel Analgesic Agents, Anesthesiology, vol.89, issue.5, 1998.
DOI : 10.1097/00000542-199811000-00003

R. K. Briggs, Drugs in pregnancy and lactation, 2008.

N. Buckholtz and Z. D. , Lysergic acid diethylamide (LSD) administration selectively downregulates serotonin2 receptors in rat brain, Neuropsychopharmacology, issue.2, pp.3137-3185, 1990.

J. Bunzow and S. M. , Amphetamine, 3,4-Methylenedioxymethamphetamine, Lysergic Acid Diethylamide, and Metabolites of the Catecholamine Neurotransmitters Are Agonists of a Rat Trace Amine Receptor, Molecular Pharmacology, vol.60, issue.6, pp.601181-601189, 2001.
DOI : 10.1124/mol.60.6.1181

J. W. Busch-ak, 08). L.S.D. 25 as an aid in psychotherapy; preliminary report of a new drug, Dis Nerv Syst, vol.11, issue.8, pp.241-244, 1950.

G. G. Caddy, Ketamine as the prototype glutamatergic antidepressant: pharmacodynamic actions, and a systematic review and meta-analysis of efficacy, Therapeutic Advances in Psychopharmacology, vol.13, issue.2, pp.4-75, 2014.
DOI : 10.1371/journal.pone.0051910

J. Callaway and G. C. , Ayahuasca Preparations and Serotonin Reuptake Inhibitors: A Potential Combination for Severe Adverse Interactions, Journal of Psychoactive Drugs, vol.148, issue.4, pp.30367-30376, 1998.
DOI : 10.1016/0140-6736(93)92774-N

A. M. Callaway, Platelet serotonin uptake sites increased in drinkers of ayahuasca, Psychopharmacology (Berl), issue.113, pp.116385-116392, 1994.

D. M. Callaway, Pharmacokinetics of Hoasca alkaloids in healthy humans, Journal of Ethnopharmacology, vol.65, issue.3, pp.243-256, 1999.
DOI : 10.1016/S0378-8741(98)00168-8

U. B. Canal and -. , The serotonin 2C receptor potently modulates the head-twitch response in mice induced by a phenethylamine hallucinogen, Psychopharmacology, vol.69, issue.6, pp.163-174, 2010.
DOI : 10.1007/s00213-002-1252-6

O. Carter and B. D. , Using Psilocybin to Investigate the Relationship between Attention, Working Memory, and the Serotonin 1A and 2A Receptors, Journal of Cognitive Neuroscience, vol.167, issue.10, pp.171497-508, 2005.
DOI : 10.1016/0010-0285(92)90010-Y

. Chambon, La médecine psychédélique, 2009.

L. Chen and H. L. , Sustained potentiation of NMDA receptor-mediated glutamate responses through activation of protein kinase C by a ?? opioid, clinicaltrial. (s.d.). Récupéré sur Clinicaltrial, pp.319-345, 1991.
DOI : 10.1016/0896-6273(91)90270-A

A. G. Cozzi, Dimethyltryptamine and other hallucinogenic tryptamines exhibit substrate behavior at the serotonin uptake transporter and the vesicle monoamine transporter, Journal of Neural Transmission, vol.87, issue.Pt 2, pp.1591-1599, 2009.
DOI : 10.1007/BF00276707

. Eisenach, 02) Preemptive hyperalgesia, not analgesia ? Anesthesiology, pp.92308-92317, 2000.
DOI : 10.1097/00000542-200002000-00009

K. Elliott and K. B. , N-methyl-D-aspartate (NMDA) receptors, mu and kappa opioid tolerance, 1995.

M. Emre and T. M. , 10) Memantine for patients with Parkinson's disease dementia or dementia with Lewy bodies : a randomised, double-blind, placebo-controlled trial, Lancet Neurol, issue.10, pp.9969-77, 2010.

W. Danysz and P. C. , Glycine and N-methyl-D-aspartate receptors : physiological significance and possible therapeutic applications, Pharmacol Rev, vol.12, issue.4, pp.50597-664, 1998.

S. De-la-monte and K. J. , 01) Human alcohol-related neuropathology, Acta Neuropathol, issue.1, pp.12771-90, 2014.

P. A. Deliganis, 06) Differential interactions of dimethyltryptamine (DMT) with 5-HT1A and 5-HT2 receptors, pp.1739-1744, 1991.

A. Denys, 07) Des plantes médicinales au servuce d'une action thérapeutique dans la prise en charge de l'addiction. Ethnopharmacologia, pp.69-78, 2013.

. Dickenson, Spinal cord pharmacology of pain, British Journal of Anaesthesia, vol.75, issue.2, pp.193-200, 1995.
DOI : 10.1093/bja/75.2.193

R. Dingledine and B. K. , 03) The glutamate receptor receptor ion channels, Pharmacol Rev, issue.1, pp.517-61, 1999.

N. Dishotsky and L. W. , LSD and Genetic Damage, Science, vol.172, issue.3982, pp.431-471, 1971.
DOI : 10.1126/science.172.3982.431

C. S. Dobkin, 06) Ayahuasca in Adolescence: Qualitative Results, Journal of Psychoactive Drugs, vol.37, issue.2, pp.135-140, 2005.

R. Doblin, Dr. Oscar Janiger's Pioneering LSD Research: A Forty Year Follow-up, MAPS, vol.9, issue.1, pp.7-21, 1999.

E. Dyck, 'Hitting Highs at Rock Bottom': LSD Treatment for Alcoholism, 1950-1970, Social History of Medicine, vol.19, issue.2, pp.313-329, 1950.
DOI : 10.1093/shm/hkl039

D. Fiorella and H. S. , 10) The role of the 5-HT2A and 5-HT2C receptors in the stimulus effects of hallucinogenic drugs. III: The mechanistic basis for supersensitivity to the LSD stimulus following serotonin depletion, Psychopharmacology, issue.3, pp.121364-72, 1995.

J. Fleurentin, Chamanisme et thérapeutique, mythe ou réalité, p.IEE ? SFE, 2005.

J. Fleurentin, Des plantes toxiques qui soignent, 2011.

P. Flood and K. M. , 05) Intravenous anesthetics differentially modulate ligand-gated ion channels, pp.921418-921443, 2000.
DOI : 10.1097/00000542-200005000-00033

D. Fontanilla and J. M. , 02) The Hallucinogen N,N-Dimethyltryptamine (DMT) Is an Endogenous Sigma-1 Receptor Regulator, Science, issue.5916, pp.323-934, 2009.

R. S. Freedland, 08) Behavioral profile of constituents in ayahuasca, an Amazonian psychoactive plant mixture, Abstract Drug and Alcohol Dependence, pp.183-194, 1998.

. Frederking, 09) [The use of narcotics (mescaline and lysergic acid diethylamide) in psychotherapy]. Psyche (Stuttg), pp.342-64, 1953.

X. Gao and S. K. , 07) Ionotropic glutamate receptors and expression of N-Methyl-Daspartate receptors subunits in subregions of human hippocampus : effects on schizophrenia, Am J Psychiatry, issue.7, pp.1571141-1571150, 2000.

. Geographic, Documentaire réalisé par le national géographique, 2009.

G. R. Greer and R. T. , A Method of Conducting Therapeutic Sessions with MDMA, Journal of Psychoactive Drugs, vol.18, issue.4, pp.10-12, 1998.
DOI : 10.1111/j.1360-0443.1992.tb02003.x

A. Giannini and U. N. , Acute Ketamine Intoxication Treated by Haloperidol, American Journal of Therapeutics, vol.7, issue.6, pp.7389-91, 2000.
DOI : 10.1097/00045391-200007060-00008

. Giove, La Liana de los muertos al rescate de la vida-7 anos de experiencia del centro Takiwasi, 2002.

H. Gottrup, B. F. , and -. , Peripheral lidocaine but not ketamine inhibits capsaicine induced hyperalggesia in humans, Anaesth, vol.10, issue.4, pp.85520-85528, 2000.

W. R. Griffiths, Mystical-type experiences occasioned by psilocybin mediate the attribution of personal meaning and spiritual significance 14 months later, Journal of Psychopharmacology, vol.5, issue.6, pp.1-12, 2008.
DOI : 10.1007/BF00412109

C. Grob and D. A. , Pilot Study of Psilocybin Treatment for Anxiety in Patients With Advanced-Stage Cancer, Archives of General Psychiatry, vol.68, issue.1, pp.6871-6879, 2011.
DOI : 10.1001/archgenpsychiatry.2010.116

Z. B. Grof, The Holotropic Mind: The Three Levels of Human Consciousness and How They Shape Our Lives, 1993.

B. Guignard and B. A. , 08) Acute opioid tolerance ; intraoperative remifentanil increases postoperative pain and morphine requirement, Anesthesiology, issue.2, pp.93409-93426, 2000.

M. Hautefeuille, Drogues à la carte, 2002.

J. Halpern and S. R. , Response of cluster headache to psilocybin and LSD, p.27, 2006.

H. G. Halpern, 03) Hallucinogen persisting perception disorder: what do we know after 50 years ? Drug & Alcohol Dependence, pp.109-119, 2003.
DOI : 10.1016/s0376-8716(02)00306-x

H. G. Halpern, Hallucinogen persisting perception disorder: what do we know after 50 years? Drug and alcohol dependence, pp.109-119, 2003.
DOI : 10.1016/s0376-8716(02)00306-x

H. Linton and R. L. , Subjective Reactions to Lysergic Acid Diethylamide (LSD-25), Archives of General Psychiatry, vol.6, issue.5, 1962.
DOI : 10.1001/archpsyc.1962.01710230020003

C. Heaven, Plant Spirit Shamanism: Traditional Techniques for Healing the Soul, 2006.

L. Hermle and G. E. , 07) Blood flow and cerebral laterality in the mescaline model of psychosis, Pharmacopsychiatry, issue.2, pp.31-85, 1998.

S. Herroeder and S. M. , Magnesium???Essentials for Anesthesiologists, Anesthesiology, vol.114, issue.4, pp.971-93, 2011.
DOI : 10.1097/ALN.0b013e318210483d

URL : http://anesthesiology.pubs.asahq.org/data/journals/jasa/931106/0000542-201104000-00037.pdf

A. Hofmann, LSD -My Problem Child, 1980.

A. Hofmann, LSD, mon enfant terrible, 1997.

J. Holland, Ecstasy : the complete guide, 2001.

A. Huxley, Les portes de la perception, 1954.

M. Johnson and G. A. , R agonist psilocybin in the treatment of tobacco addiction, Journal of Psychopharmacology, vol.27, issue.11, pp.28983-92, 2014.
DOI : 10.1111/j.1360-0443.2008.02348.x

W. R. Johnson, Human hallucinogen research: guidelines for safety, Journal of Psychopharmacology, vol.7, issue.28, pp.603-620, 2008.
DOI : 10.1007/BF00412109

V. S. Keiser, Predicting new molecular targets for known drugs, Nature, vol.99, issue.7270, pp.462-175, 2009.
DOI : 10.1177/009127006200200605

C. Kentros and H. E. , Abolition of Long-Term Stability of New Hippocampal Place Cell Maps by NMDA Receptor Blockade, Science, vol.280, issue.5372, pp.2802121-2802127, 1998.
DOI : 10.1126/science.280.5372.2121

R. Kohrs and D. M. , Ketamine : teaching an old drug new tricks, pp.1186-93, 1998.

. Kolp, 12) Eleusis Offers Ketamine Psychedelic Psychotherapy, MAPS, vol.15, issue.3, pp.13-14, 2005.

K. Experience, Récupéré sur http://kolpinstitute.org/: http://kolpinstitute.org/ketamine-induced-transpersonal-expedience

K. Kolp, Ketamine-Enhanced Psychotherapy: Preliminary Clinical Observations on its Effects in Treating Death Anxiety, International Journal of Transpersonal Studies, vol.26, issue.1, pp.1-17, 2007.
DOI : 10.24972/ijts.2007.26.1.1

E. Krupitsky and B. A. , Ketamine psychotherapy for heroin addiction: immediate effects and two-year follow-up, Journal of Substance Abuse Treatment, vol.23, issue.4, pp.273-283, 2002.
DOI : 10.1016/S0740-5472(02)00275-1

E. Krupitsky and B. A. , 03) Single versus repeated sessions of ketamine-assisted psychotherapy for people with heroin dependence, J Psychoactive Drugs, issue.1, pp.3913-3922, 2007.

G. Krupitsky, Ketamine Psychedelic Therapy (KPT): A Review of the Results of Ten Years of Research, Journal of Psychoactive Drugs, vol.5, issue.2, pp.165-183, 1997.
DOI : 10.1300/J020V01N01_02

P. J. Krebs, ??? 08-03) Lysergic acid diethylamide (LSD) for alcoholism: metaanalysis of randomized controlled trials, J Psychopharmacol, 2012.

A. Kudoh and T. Y. , Small-Dose Ketamine Improves the Postoperative State of Depressed Patients, Anesthesia & Analgesia, vol.95, issue.1, pp.95114-95122, 2002.
DOI : 10.1097/00000539-200207000-00020

B. L. Li, mTOR-Dependent Synapse Formation Underlies the Rapid Antidepressant Effects of NMDA Antagonists, Science, vol.116, issue.6, pp.329-959, 2010.
DOI : 10.1097/JCP.0b013e31818a6cea

H. Lotsof, Bill O'reilly Interviews Howard Lotsof on Ibogaine, 1995.

L. S. Ludwig, A Clinical Study of LSD Treatment in Alcoholism, American Journal of Psychiatry, vol.126, issue.1, pp.59-69, 1969.
DOI : 10.1176/ajp.126.1.59

J. Mabit, L'hallucination par l'Ayahuasca chez les guérisseurs de la Haute-Amazonie péruvienne Récupéré sur takiwasi: http://www.takiwasi.org/docs/arti_fra/hallucination_par_ayahuasca_chez_les_guerisseurs Ayahuasca in the treatment of Addictions, pdf Mabit, 1989.

. Mabit, 01) Séminaire d'Évolution Personnelle. Récupéré sur Takiwasi: http://www.takiwasi.com/fra/se01, 2012.

. Malleson, 02) Acute adverse reactions to LSD in clinical and experimental use in the United Kingdom, pp.118229-118259, 1971.

T. Mantere and T. E. , Serotonin Transporter Distribution and Density in the Cerebral Cortex of Alcoholic and Nonalcoholic Comparison Subjects: A Whole-Hemisphere Autoradiography Study, American Journal of Psychiatry, vol.159, issue.4, pp.159599-606, 2002.
DOI : 10.1176/appi.ajp.159.4.599

J. Mao and P. D. , Mechanisms of hyperalgesia and tolerance : a current view of their possible interactions, Pain, issue.093, pp.62259-74, 1995.

D. Marona-lewicka and T. R. , 07). istinct temporal phases in the behavioral pharmacology of LSD: dopamine D2 receptor-mediated effects in the rat and implications for psychosis, Psychopharmacology (Berl), issue.3, pp.180427-180462, 2005.

W. Martin and M. A. , PKCgamma contributes to a subset of the NMDA-dependent spinal circuits that underlie injury-induced persistent pain, J Neurosci, issue.1514, pp.215321-215328, 2001.

D. Martin and M. D. , Chronic LSD alters gene expression profiles in the mPFC relevant to schizophrenia, Neuropharmacology, vol.83, pp.1-8, 2014.
DOI : 10.1016/j.neuropharm.2014.03.013

H. R. May, H]Harman Binding Experiments. I: A Reversible and Selective Radioligand for Monoamine Oxidase Subtype A in the CNS of the Rat, Journal of Neurochemistry, vol.260, issue.2, pp.490-499, 1991.
DOI : 10.1007/978-1-4899-7321-4_14

. Mccabe, Psychedelic Drug Crises: Toxicity and Therapeutics, Journal of Psychedelic Drugs, vol.1, issue.1, pp.107-121, 1977.
DOI : 10.1080/00332747.1963.11023344

M. Kenna and T. , Ayahuasca : An Ethnopharmacologic History, 1999.

D. J. Mckenna, Clinical investigations of the therapeutic potential of ayahuasca: rationale and regulatory challenges, Pharmacology & Therapeutics, vol.102, issue.2, pp.111-129, 2004.
DOI : 10.1016/j.pharmthera.2004.03.002

M. T. Mithoefer, The safety and efficacy of ??3,4-methylenedioxymethamphetamine-assisted psychotherapy in subjects with chronic, treatment-resistant posttraumatic stress disorder: the first randomized controlled pilot study, Journal of Psychopharmacology, vol.161, issue.4, pp.439-452, 2011.
DOI : 10.1016/j.yhbeh.2005.07.009

L. Mony and K. J. , 08) Allosteric modulators of NR2B-containing NMDA receptors : molecular mechanisms and therapeutic potential, Br J Pharmacol, vol.121, issue.8, pp.1571301-1571318, 2009.

F. Moreno and W. C. , Safety, Tolerability, and Efficacy of Psilocybin in 9 Patients With Obsessive-Compulsive Disorder, The Journal of Clinical Psychiatry, vol.67, issue.11, pp.671735-671775, 2006.
DOI : 10.4088/JCP.v67n1110

A. Muller and T. E. , Récepteurs NMDA et douleurs, Cah Anesthesiol, vol.47, pp.161-177, 1999.

U. Muth-selbach and D. E. , 09) The spinal antinociceptive effect of nocistatin in neuropathic rats is blocked by D-serine, Anesthesiology, issue.3, pp.101753-101761, 2004.

P. Naranjo, Ayahuasca : etnomedicina y mitologia, 1983.

. Neuroplasticite, Glutamate et schizophrénie Récupéré sur Neuroplasticite, 2014.

C. Nichols and S. E. , A Single Dose of Lysergic Acid Diethylamide Influences Gene Expression Patterns within the Mammalian Brain, Neuropsychopharmacology, vol.26, issue.5, pp.26634-26676, 2002.
DOI : 10.1016/S0893-133X(01)00405-5

D. Nichols, F. S. , and -. , Lysergamides of isomeric 2,4-dimethylazetidines map the binding orientation of the diethylamide moiety in the potent hallucinogenic agent N,Ndiethyllysergamide (LSD), J Med Chem, issue.12, pp.454344-454353, 2002.

. Nichols, Hallucinogens, Pharmacology & Therapeutics, vol.101, issue.2, pp.131-81, 2004.
DOI : 10.1016/j.pharmthera.2003.11.002

S. Nichols, 08) Molecular genetic responses to lysergic acid diethylamide include transcriptional activation of MAP kinase phosphatase-1, C/EBP-beta and ILAD-1, a novel gene with homology to arrestins, J Neurochem, issue.3, pp.90576-84, 2004.

. Novak, 03) LSD before Leary Sidney Cohen's critique of 1950s psychedelic drug research, Isis, issue.1, pp.8887-110, 1997.

J. Olney and W. D. , Drug-induced apoptic neurodegeneration in the developing brain, Brain Pathol, vol.10, issue.124, pp.488-98, 2002.

O. Jw and L. J. , Pathological changes induced in cerebrocortical neurons by phencyclidine and related drugs, Science, issue.164910, pp.2441360-2441362, 1989.

A. Ostermeier and S. B. , Activation of ??- and ??-Opioid Receptors Causes Presynaptic Inhibition of Glutamatergic Excitation in Neocortical Neurons, Anesthesiology, vol.93, issue.4, pp.1053-63, 2000.
DOI : 10.1097/00000542-200010000-00029

A. Ouagazzal and G. A. , Effect of LSD on Prepulse Inhibition and Spontaneous Behavior in the Rat A Pharmacological Analysis and Comparison between Two Rat Strains, Neuropsychopharmacology, vol.25, issue.4, 2001.
DOI : 10.1016/S0893-133X(01)00282-2

W. Pahnke, 01) The psychedelic mystical experience in the human encounter with death, pp.1-21, 1969.

J. W. Pender, Dissociative Anesthesia, Calif Med, issue.115, pp.113-73, 1970.
DOI : 10.1001/jama.215.7.1126

URL : http://europepmc.org/articles/pmc1501800?pdf=render

A. Petrenko and Y. T. , The role of N-Methyl-D-Aspartate (NDMA) Receptors in Pain : A review, Anesth Analg, vol.10, issue.4, pp.971108-971124, 2003.

S. J. Pierce, Hallucinogenic drug interactions with neurotransmitter receptor binding sites in human cortex, Psychopharmacology, vol.68, issue.1, pp.118-122, 1989.
DOI : 10.1007/BF00443425

M. Sadove and S. M. , Analgesic effects of ketamine administered in subdissociative doses, Anesth Analg, issue.3, pp.5-06, 1971.

. Sandison, Further Studies in the Therapeutic Value of Lysergic Acid Diethylamide in Mental Illness, Journal of Mental Science, vol.103, issue.431, pp.332-343, 1954.
DOI : 10.1192/bjp.103.431.332

S. A. Sandison-ra, The Therapeutic Value of Lysergic Acid Diethylamide in Mental Illness, Journal of Mental Science, vol.100, issue.419, pp.491-507, 1954.
DOI : 10.1192/bjp.100.419.491

M. M. Samoylenko, 02 03) Banisteriopsis caapi, a unique combination of MAO inhibitory and antioxidative constituents for the activities relevant to neurodegenerative disorders and Parkinson's disease, Journal of ethnopharmacology, issue.2, pp.127-357, 2010.

. Saunders, 03 12) Clinical Management of Poisoning and Drug Overdose. The New England Journal of Medecine, pp.771-772, 1998.

M. Savage, Residential Psychedelic (LSD) Therapy for the Narcotic Addict, Archives of General Psychiatry, vol.28, issue.6, pp.808-814, 1973.
DOI : 10.1001/archpsyc.1973.01750360040005

H. Schultes, Les Plantes des Dieux, 2000.

D. Simeon and G. S. , 08) Feeling unreal: 30 cases of DSM-III-R depersonalization disorder, Am J Psychiatry, issue.8, pp.1541107-1541120, 1997.

A. Shulgin, Pihkal: A Chemical Love Story, 1995.

. Shpilenia, Experience with the use of ketamine in psychiatric practice, Zh Nevropatol Psikhiatr, vol.84, issue.3, pp.418-440, 1984.

R. L. Smith, C. H. , and -. , Agonist Properties of N,N-Dimethyltryptamine at Serotonin 5-HT2A and 5-HT2C Receptors, Pharmacology Biochemistry and Behavior, vol.61, issue.3, pp.61323-61353, 1998.
DOI : 10.1016/S0091-3057(98)00110-5

K. Song and Z. Z. , 05) Cooperative interaction among the various regulatory sites within the NMDA receptor-channel complex in modulating the evoked responses to noxious thermal stimuli of dorsal horn neurons on the cat, Exp Brain Res, issue.2, pp.120257-62, 1998.

. Soskin, 12) The use of LSD in time-limited psychotherapy, J Nerv Ment Dis, issue.6, pp.157410-157419, 1973.

G. Stix, 09 13) Ketamine, a Darling of the Club Scene, Inspires Development of Next-Generation Antidepressants, Part 3. Récupéré sur Scientific American: http://blogs.scientificamerican.com/talking-back/2013/09/13/ketamine-a-darling-of-the-club- scene-inspires-next-generation-antidepressants-part-3, 2013.

. Strassman, ADVERSE REACTIONS TO PSYCHEDELIC DRUGS. A REVIEW OF THE LITERATURE, The Journal of Nervous and Mental Disease, vol.172, issue.10, 1984.
DOI : 10.1097/00005053-198410000-00001

R. J. Strassman, C. R. Qualls, E. H. Uhlenhuth, and R. M. Kellner, Dose-Response Study of N,N-Dimethyltryptamine in Humans, Archives of General Psychiatry, vol.51, issue.2, pp.51-98, 1994.
DOI : 10.1001/archpsyc.1994.03950020022002

T. H. Su, When the Endogenous Hallucinogenic Trace Amine, 2009.

T. Ray, 03) Psychedelics and the Human Receptorome, PLoS One, issue.3, pp.5-10, 2010.

M. P. Ravalec, Bois Sacré, Initiation à l'iboga, 2004.

M. H. Rothman, Serotonergic drugs and valvular heart disease, Expert Opinion on Drug Safety, vol.9, issue.3, 2010.
DOI : 10.1111/j.1360-0443.2006.01314.x

URL : http://europepmc.org/articles/pmc2695569?pdf=render

P. L. Thomas, Ayahuasca-Assisted Therapy for Addiction: Results from a Preliminary Observational Study in Canada, Current Drug Abuse Reviews, vol.6, issue.1, pp.30-42, 2013.
DOI : 10.2174/15733998113099990003

J. Tiihonen and K. J. , Single-photon emission tomography imaging of monoamine transporters in impulsive violent behaviour, European Journal of Nuclear Medicine and Molecular Imaging, vol.24, issue.10, pp.241253-60, 1997.
DOI : 10.1007/s002590050149

V. Todorovic and W. D. , A comparative evaluation of the neurotoxic properties of ketamine and nitrous oxide, Brain Research, vol.895, issue.1-2, pp.264-271, 0323.
DOI : 10.1016/S0006-8993(01)02079-0

D. Turner, The essential psychedelic guide, 1994.

A. G. Vollenweider, Neural Correlates of Hallucinogen-induced Altered States of Consciousness. Récupéré sur http, 1998.

M. Wakasugi and H. K. , 03) The effects of general anesthetics on excitatory and inhibitory synaptic transmission in area CAI of the rat hippocampus un vitro, pp.88676-80, 1999.

Y. Wang and S. V. , Composition, standardization and chemical profiling of Banisteriopsis caapi, a plant for the treatment of neurodegenerative disorders relevant to Parkinson's disease, Journal of Ethnopharmacology, vol.128, issue.3, pp.128662-71, 2010.
DOI : 10.1016/j.jep.2010.02.013

T. Weiner, 03) Sidney Gottlieb, 80, Dies; Took LSD to C.I.A. The News York times, 1999.

B. Weniger, Les champigons psychotropes d'Amérique centrale et leurs usages, 2009.

. White, 3,4-Methylenedioxymethamphetamine???s (MDMA???s) Impact on Posttraumatic Stress Disorder, Annals of Pharmacotherapy, vol.40, issue.7, pp.48908-915, 2014.
DOI : 10.1002/jcph.266

J. Winter and E. J. , Serotonergic/glutamatergic interactions: the effects of mGlu2, 2004.

R. Wyatt and S. J. , A Dimethyltryptamine-Forming Enzyme in Human Blood, American Journal of Psychiatry, vol.130, issue.7, pp.130754-60, 1973.
DOI : 10.1176/ajp.130.7.754

T. Yamakura and S. K. , Direct Inhibition of the N-methyl-D-aspartate Receptor Channel by High Concentrations of Opioids, Anesthesiology, vol.91, issue.4, pp.911053-63, 1999.
DOI : 10.1097/00000542-199910000-00026

R. Yensen, Addiction, Despair, and the Soul: Successful Psychedelic Psychotherapy, A Case Study Récupéré sur http, p.lsd- psyshedelic-psychotherapy, 1995.

C. Zarate and S. J. Jr, A Randomized Trial of an N-methyl-D-aspartate Antagonist in Treatment-Resistant Major Depression, Archives of General Psychiatry, vol.63, issue.8, pp.63856-64, 2006.
DOI : 10.1001/archpsyc.63.8.856

Z. Zhou and Z. Z. , Ketamine blockage of both tetrodotoxin (TTX)-sensitive and TTX-resistant sodium channels of rat dorsal root ganglion neurons, Brain Research Bulletin, vol.52, issue.5, pp.52427-52460, 2000.
DOI : 10.1016/S0361-9230(00)00283-5